RICTOR and breast cancer: Therefore, we hypothesized that RICTOR (mTORC2) might regulate the sphingolipid metabolism, and increased levels of glucosylceramides may be instrumental for enhanced cancer cell proliferation and tumor progression in luminal breast cancer patients (Fig 1T).